The short version of GHRH analog fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-05-02 and is reviewed periodically as new material appears.
Two related forms appear under the CJC-1295 name. The simpler analogue, commonly written as modified GRF(1-29), carries the four substitutions but no additional conjugation. The second form attaches a maleimidopropionic acid linker to a lysine residue, a modification frequently called the drug affinity complex. That linker reacts with the free thiol on serum albumin to form a covalent bond. Because albumin has a long residence time in blood, the conjugated peptide stays in circulation far longer than the unconjugated analogue.
Receptor level activity follows the canonical GHRH pathway. The peptide binds the GHRH receptor, a class B G protein coupled receptor on somatotroph cells of the anterior pituitary. Binding raises intracellular cyclic AMP, which promotes calcium entry and the release of growth hormone into the bloodstream. Because the molecule acts at the same receptor as the endogenous hormone, its effect is superimposed on the natural pulsatile rhythm rather than replacing it. Whether sustained receptor occupation leads to desensitization is not fully settled.
At the pituitary, the peptide binds the growth hormone-releasing hormone receptor on somatotroph cells. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone. Somatostatin and other hypothalamic signals modulate this response. Negative feedback from insulin-like growth factor 1 also influences output. The same regulatory architecture operates with the native hormone. Whether the synthetic analog alters feedback dynamics over repeated exposure remains an open question. Most published receptor work uses cell models rather than intact human systems.
CJC-1295 is a synthetic peptide belonging to the growth hormone-releasing hormone analog family. It comprises twenty-nine amino acid residues derived from the N-terminal region of natural GHRH. The molecule incorporates several non-natural substitutions that increase resistance to enzymatic degradation. These modifications extend its activity compared with the native hormone fragment. Researchers use it to study pituitary growth hormone secretion in laboratory and clinical settings. This compound is distinct from native GHRH in its stability profile.
Two principal forms appear in the literature and in research supply. One carries a drug affinity complex, a maleimide-based group that forms a covalent bond with circulating albumin. This linkage slows clearance and produces a long-lasting elevation of peptide levels. The other form lacks that group and is often labeled MOD GRF(1-29). It has a much shorter circulation time. Both variants retain the same core receptor-binding sequence. Reported half-lives differ substantially between the two.
| Property | Value | Notes |
|---|---|---|
| Peptide class | Synthetic GHRH analogue | Built on a 29 residue sequence |
| Primary target | GHRH receptor (GHRHR) | Class B G protein coupled receptor |
| Unconjugated half life | Minutes | Limited by protease degradation |
| Key modification | Four residue substitutions | Positions 2, 8, 15 and 27 |
| Common synonym | Modified GRF(1-29) | Usually denotes the form without DAC |
Two related forms circulate in technical discussion under the same family name. The original version carries a drug affinity complex (DAC) that binds covalently to serum albumin after administration, and this linkage substantially extends circulation time. A second form, frequently written as modified GRF(1-29) or CJC-1295 without DAC, lacks that linker and clears much faster. The naming is a frequent source of confusion because the shorthand CJC-1295 can refer to either form depending on the source. Reports sometimes fail to specify which variant was studied.
The peptide backbone includes a D-alanine at position two, which resists cleavage by dipeptidyl peptidase IV, and several other substitutions that reduce degradation. Its molecular weight is roughly 3.4 kDa without the linker and about 3.6 kDa with it. The molecule is water soluble and is normally supplied as a lyophilized powder. Precise sequence and mass values depend on which variant is described, so technical documents usually state the exact form being referenced.
Reports on this compound commonly follow serum growth hormone and insulin-like growth factor 1 across defined time windows. Protocols differ in sampling frequency, assay platform, and participant characteristics, which makes direct comparison between publications difficult. Some work focuses on pulsatile release patterns instead of average concentrations. Whether repeated exposure alters endogenous hormone rhythms over long periods remains an open question, and the formal literature is thinner than the volume of informal commentary implies.
Once in circulation, the peptide binds the growth hormone-releasing hormone receptor displayed on pituitary somatotroph cells. Receptor activation couples to Gs proteins, elevates intracellular cyclic AMP, and drives protein kinase A signaling inside the cell. That cascade increases discharge of growth hormone into the bloodstream. The analog therefore operates through a receptor pathway that already exists for the body's own releasing hormone, rather than through an engineered artificial target.
Some women with ptosis choose to undergo plastic surgery to make their breasts less ptotic. Plastic surgeons offer several procedures for lifting sagging breasts. Surgery to correct the size, contour, and elevation of sagging breasts is called mastopexy. Women can also choose breast implants, or may undergo both procedures. The breast-lift procedure surgically elevates the parenchymal tissue (breast mass), cuts and re-sizes the skin envelope, and transposes the nipple-areola complex higher upon the breast hemisphere. If sagging is present and the woman opts not to undergo mastopexy, implants are typically placed above the muscle, to fill out the breast skin and tissue. Submuscular placement can result in deformity. In these cases, the implant appears to be high on the chest, while the natural breast tissue hangs down over the implant.
In 1929–30, Parke, Davis & Co., a major US drug manufacturer based in Detroit, Michigan, sold "Opium, U.S.P. (Laudanum)", as Tincture No. 23, for $10.80 per pint (16 fluid ounces), and "Opium Camphorated, U.S.P. (Paregoric)", as Tincture No. 20, for $2.20 per pint. Concentrated versions were available. "Opium Camphorated, for U.S.P. Tincture: Liquid No. 338" was "exactly 8 times the strength of Tincture Opium Camphorated (Paregoric) [italics in original], U.S.P., "designed for preparing the tincture by direct dilution," and cost $7 per pint. Similarly, at a cost of $36 per pint, "Opium Concentrated, for U.S.P. Tincture: Liquid No. 336", was "four times the strength of the official tincture", and "designed for the extemporaneous preparation of the tincture". The catalog also noted: "For quarter-pint bottles add 80c. per pint to the price given for pints." Toward the middle 20th century, the use of opiates was generally limited to the treatment of pain, and opium was no longer a medically accepted 'cure-all'. Further, the pharmaceutical industry began synthesizing various opioids, such as propoxyphene, oxymorphone and oxycodone. These synthetic opioids, along with codeine and morphine were preferable to laudanum since a single opioid could be prescribed for different types of pain rather than the 'cocktail of laudanum, which contains nearly all of the opium alkaloids. Consequently, laudanum became mostly obsolete as an analgesic, since its principal ingredient is morphine, which can be prescribed by itself to treat pain.
== Assessments == A December 2024 Gallup poll found that 54% of Americans thought Biden's presidency was below average or poor, 26% average, and 19% above average or outstanding. Gallup found that Americans largely offered negative assessments of Biden's presidency on economic, national, and international issues. Of 18 issue areas Gallup tracked, a majority of Americans said the U.S. lost ground in six, including the economy in general, immigration, and the country's position in the world. A plurality found that the U.S. declined in six other areas, including national infrastructure and energy, education, and trade relations with other countries. A plurality felt the U.S. made progress in only one indicator under Biden: the conditions of gay, lesbian, and transgender people. When Biden left office in 2025, journalists and many Democrats viewed his presidency as a failure due to age and health concerns, public frustration over inflation, and Harris's loss to Trump in the 2024 presidential election. The Guardian called the conclusion of Biden's presidency a "tragedy".
=== Early indications === The syntheses of elements 107 to 112 were conducted at the GSI Helmholtz Centre for Heavy Ion Research in Darmstadt, Germany, from 1981 to 1996. These elements were made by cold fusion reactions, in which targets made of lead and bismuth, which are around the stable configuration of 82 protons, are bombarded with heavy ions of period 4 elements. This creates fused nuclei with low excitation energies due to the stability of the targets' nuclei, significantly increasing the yield of superheavy elements. Cold fusion was pioneered by Yuri Oganessian and his team in 1974 at the Joint Institute for Nuclear Research (JINR) in Dubna, Soviet Union. Yields from cold fusion reactions were found to decrease significantly with increasing atomic number; the resulting nuclei were severely neutron-deficient and short-lived. The GSI team attempted to synthesise element 113 via cold fusion in 1998 and 2003, bombarding bismuth-209 with zinc-70; both attempts were unsuccessful. Faced with this problem, Oganessian and his team at the JINR turned their renewed attention to the older hot fusion technique, in which heavy actinide targets were bombarded with lighter ions. Calcium-48 was suggested as an ideal projectile, because it is very neutron-rich for a light element (combined with the already neutron-rich actinides) and would minimise the neutron deficiencies of the nuclides produced. Being doubly magic, it would confer benefits in stability to the fused nuclei.
== Further reading == De Iuliis, Gerardo; Pulerà, Dino (2019). "Vertebrates and Their Kin". The Dissection of Vertebrates. pp. 1–44. doi:10.1016/B978-0-12-410460-0.00001-2. ISBN 978-0-12-410460-0. Myomeres are the segmented paired muscular blocks that extend through the trunk and tail. Alternating contraction of the musculature of the right and left sides of the body exerts forces on the notochord, noted earlier as a laterally flexible rod, that allow the side-to-side locomotory movements characteristic of less derived chordates and vertebrates. Johnston, I.A. (2008). "The biological basis of variability in the texture of fish flesh". Improving Seafood Products for the Consumer. pp. 465–489. doi:10.1533/9781845694586.5.465. ISBN 978-1-84569-019-9. The fillet is made up of segmentally arranged structures called myotomes or myomeres, the shape of which varies along the length of the body. In three dimensions, the myomeres constitute a series of overlapping cones that are bounded by connective tissue sheets or myocommata called myosepta. Typically, a transverse steak through the fillet will cut through several myotomes at different levels. Each myotome contains a lateral superficial strip of dark muscle primarily composed of slow contracting fibre types that are used for sustained swimming activity (Johnston et al., 1977).
Sources: en.wikipedia.org
The challenge of sustaining Nancy as a Ligue 1 club was difficult as Wenger inherited a squad of sub-standard quality and he was given limited money to spend. He nevertheless relished the prospect of conducting business in the transfer market, and enjoyed freedom to trial theories he read about. In his first season at Nancy, Wenger hired a dietician to explain the benefits of healthy eating and made it imperative that players did not snack before games. He took the squad away from their usual summer training camp to Val Thorens, so that the players could acclimatise to the high-altitude. Platini attested the move to their strong league starts. From a managerial perspective, Wenger struggled to keep his emotions in check; losing made him "physically sick", to the point where he once stopped the team bus to vomit after a game. Wenger guided the club to a respectable 12th-place finish, all the more surprising given he constantly tinkered his team. Players were moved out of their favoured positions, which for some maximised their potential. Éric Bertrand, a striker signed from the lower divisions, was converted into a fullback, and by the end of Wenger's time at Nancy, Éric Di Meco switched from a left winger to wing back.
=== Silver Medal at 1948 Summer Olympics === Yugoslavia began their football campaign by defeating Luxembourg 6–1, with five different players scoring the goals. In the quarter-finals and the semi-finals, they would take out Turkey and Great Britain by the same score of 3–1. In the final though, they would lose to Sweden.
==== William Henry Perkin’s mauveine ==== In 1856, 18 year old William Perkin accidentally discovered a dye he called mauve while trying to make quinine from the oxidation of allyl toluene in his home lab for his academic advisor and boss August Wilhelm von Hoffman. Hoffman reportedly referred to aniline, a major step in the synthesis, as his "first love," and was excited to have Perkin working with it. Perkin communicated with the textile industry, including Pullars of Perth, and John Hyde Christie, the chemist and general manager of John Orr Ewing and Co. about how to best market and produce his dye. He started production of aniline purple near London at the end of 1857 and remained the only producer for at least a few months. Perkin began making the intermediates for his dyes in-house, for example, nitro-benzene, expanding the scale of operations. By the summer of 1859, according to a satirical magazine Punch, London had fallen ill with 'the mauve measles'.
Soon after settling into his new home on Riverside Drive, Adorno met with Lazarsfeld in Newark, New Jersey, to discuss the Project's plans for investigating the impact of broadcast music. Although he was expected to embed the Project's research within a wider theoretical context, it soon became apparent that the Project was primarily concerned with data collection to be used by administrators for establishing whether groups of listeners could be targeted by broadcasts specifically aimed at them. Expected to make use of devices with which listeners could press a button to indicate whether they liked or disliked a particular piece of music, Adorno bristled with distaste and astonishment: "I reflected that culture was simply the condition that precluded a mentality that tried to measure it." Thus, Adorno suggested using individual interviews to determine listener reactions and, only three months after meeting Lazarsfeld, completed a 160-page memorandum on the Project's topic, "Music in Radio." Adorno was primarily interested in how musical material was affected by its distribution through the medium of radio and thought it imperative to understand how music was affected by its becoming part of daily life.
Sources: en.wikipedia.org
The names are often used interchangeably in casual writing, but they are not strictly identical. Modified GRF(1-29) refers to the unconjugated analogue carrying only the four substitutions. The version sold as CJC-1295 with DAC includes the albumin binding linker and clears much more slowly.
DAC stands for drug affinity complex, a term describing the maleimidopropionic acid linker. This group forms a covalent bond with the cysteine residue on serum albumin after administration. The resulting adduct is what extends the circulating half life from minutes to days.
No. It is entirely synthetic and does not correspond to any known endogenous peptide. The design starts from human growth hormone releasing hormone and introduces deliberate substitutions. Any biological effect comes from mimicking the natural hormone at its receptor.
It is a synthetic peptide modeled on growth hormone-releasing hormone. The molecule is used in research on pituitary growth hormone secretion. It differs from the natural hormone through several stabilizing substitutions.